EyeWorld Asia-Pacific December 2011 Issue

December 2011 13 EW FEATURE *SUPRACOR for myopic, emmetropic, and post-LASIK patients is currently in clinical evaluation Some of the products and/or specific features as well as the procedures featured in this document may not be approved in your country and thus may not be available there. Design and specifications are subject to change without prior notice as a result of ongoing technical development. SUPRACOR is CE marked. SUPRACOR is NOT approved for use in the US. Please contact our regional representative regarding individual availability in your respective market. The trademarks (™ and ®) and logos used in this document are the property ofTechnolas PerfectVision GmbH or the respective owner. Design by kbcomunicacion. Ref.TPV-087/12-2011 ©2011Technolas PerfectVision GmbH. All rights reserved. Outstanding refractive results for your patients throughout their vision lifecycle TECHNOLAS Excimer 217P Premium LASIK procedures SUPRACOR™ bilateral presbyopia treatment Satisfied patients for increased practice growth Proven long-term performance Technolas Perfect Vision GmbH Regional Office Asia-Pacific Messerschmittstr. 1 + 3, Technolas Singapore Pte Ltd 80992 München, Germany 101 Thomson Road, #27-03A United Square. Tel. +65-6592-0792 www.technolaspv.com Singapore 307591